2020 Japan HIV/AIDS Diagnostics Market: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

2020 Japan HIV/AIDS Diagnostics Market: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

  • February 2020 •
  • 60 pages •
  • Report ID: 5867320 •
  • Format: PDF
2020 Japan HIV/AIDS Diagnostics Market: Supplier Shares and Segment Forecasts for HIV 1/2, Combo, Ag, NAT and Western Blot Assays

This DataPack presents Japanese test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:

    - Hospitals
    - Commercial/Private Labs
    - Blood Banks

The DataPack also provides sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/JandJ, Roche, and Siemens.

List of Tables


Table 1  Major Companies Developing or Marketing AIDS Tests
Table 2  Japan: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3  Japan: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4  Japan: Western Blot Tests Volume and Sales Forecast by Market Segment
Table 5  Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6  Japan: AIDS Diagnostics Market by Major Supplier
Table 7  Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Contains 60 pages and 7 tables